Abstract
The first Wallstent results had high thrombosis and death. It was reported that the left anterior descending (LAD) artery was the vessel implicated in major complications that occurred in patients who received a Wallstent. Subsequently, Wallstent applications were refrained from with LAD lesions. However, the promising results of second-generation self-expanding Magic Wallstent implantation have been reported recently. The purpose of this study is to assess the immediate and intermediate clinical outcomes of patients undergoing self-expanding Magic Wallstent implantation at the LAD site and to compare those outcomes with those of a similar group of patients undergoing balloon expandable stenting at the same site. Between 1995 and 1999, 255 consecutive patients underwent LAD stenting at our center. The study population was divided into two groups based on the mode of delivery (self-expanding versus balloon-expandable) of stent design. Group I included 97 patients in whom self-expanding Magic Wallstents were implanted. Group II included 158 patients in whom various types of balloon-expandable stents were implanted. Procedural success was defined as successful deployment of the stent in the absence of adverse cardiac events (death, acute myocardial infarction, emergency coronary bypass surgery). Clinical success was defined as the absence of adverse cardiac events (death, acute myocardial infarction, emergency coronary bypass surgery, repeat balloon angioplasty) within the first two weeks. The mean follow-up period was 8 ± 5.3 months for Group I and 9.8 ± 7.5 months for Group II. There was no difference in baseline characteristics between the two groups. Fourteen patients in Group I and 22 patients in Group II had bailout procedures. The number of patients with reference vessel diameter less than 3 mm was 37 in Group I and 60 in Group II. The stent length was greater in Group I than in Group II (p=0.0003). In Group I, stenting improved minimal lumen diameter (MLD) from 0.65 ± 0.4 mm to 2.35 ± 0.4 and percent diameter stenosis (PDS) from 76.24 ± 17.3 to 22.78 ± 13.6. In Group II, stenting improved MLD from 0.73 ± 0.4 mm to 2.49 ± 0.5 and PDS from 76.71 ± 15.5 to 18.99 ± 9.6. Final MLD and final PDS improved more in Group II than Group I. Stent could not be delivered in three patients in Group I and nine in Group II. In Group II, six stents were dislocated from its delivery system. Procedural and clinical success and subacute stent thrombosis rates were 93.8%, 85.6%, and 7.2% in Group I, and 93%, 86.7%, and 5.1% in Group II, respectively. Within the first two weeks, death occurred in one patient in each group, acute myocardial infarction in four (Group I) and two (Group II) patients; coronary bypass surgery in three (Group I) and five (Group II) patients, and balloon angioplasty in two (Group I) and four (Group II) patients, respectively. In Group I, following the first two weeks, no patients died, two patients had nonfatal myocardial infarction, and coronary bypass surgery and target vessel repeat balloon angioplasty was required in five and ten patients, respectively. In Group II, one patient died in the follow-up period, there was no nonfatal myocardial infarction, and bypass surgery and target vessel repeat balloon angioplasties were required in three and eleven patients, respectively. None of these differences in clinical events was statically significant. We found that self-expanding Magic Wallstent implantation can be performed in LAD lesions and was associated with a rate of early clinical results and intermediate term clinical results similar to that of balloon-expandable stents in LAD arteries. In conclusion, the Magic Wallstent may confidently be used for LAD lesions.
Similar content being viewed by others
References
Barth KH, Virmani R, Froelich J, Takeda T, Lossef SV, Newsome J, Ones R, Indisch D (1996) Paired comparison of vascular wall reactions to Palmaz Stents, Strecker Tantalum Stents, and Wallstents in canine iliac and femoral arteries. Circulation 93:2161–2169.
Beatt KJ, Bertrand M, Puel J, Rickards T, Serruys PW, Sigward U (1989) Additional improvement in vessel lumen in the first 24 hours after stent implantation due to radial dilating force. JACC 13:224A.
Carter AJ, Scott D, Bailey L, Kim D, Devries J, Jones R, Irmani R (1997) A comparison of stent designs in small diameter porcine coronary arteries. J Am Coll Cardiol 29 (suppl A):170A. Abstract.
De Jaegere PP, Strauss BH, van der Giessen WJ, de Feyter FJ, Serruys PW (1992) Immediate changes in stenosis geometry following stent implantation: Comparison between a self expanding and a balloon expandable stent. J Interven Cardiol 5:71–78.
De Jaegere PP, Serruys PW, Bertrand M, Viegand V, Koher G, Marquis JF, Valeix B, Uebis R, Piessens J (1992) Wiktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery. Am J Cardiol 69:598–602.
Dotter CT (1969) Transluminally placed coil-spring endarterial tube grafts: long-term patency in canine popliteal artery. Invest Radiol 4:329–332.
Fischmann DL, Leon MB, Baim DS, Schatz R, Savage MB, Penn JM, Detre K, Veltri L, Ricci D, Nobuyoshi M (1994) A randomized comparison of coronery stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496–501.
Gambhir DS, Sudha R, Trehan V, Jain R, Singh S, Kaul UA, Arora R (1997) Immediate and six month outcome of self expanding Wallstent for long lesions in native coronary arteries. Indian Heart J 49(1):53–59.
Goy JJ, Eeckhout E, Stauffer JC, Vogt P (1996) Stenting of the right coronary artery for de novo stenoses: A comparison of the Wiktor and the Palmaz-Schatz stents. Circulation 93:2161–2169.
Goy JJ, Sigwart U, Vogt P, Stauffer JC, Kaufmann U, Urban P, Keppenberger L (1991) Long term follow up of the first 56 patients treated with intracoronary self expandable stents (The Lausanne experience). Am J Cardiol 67:569–572.
Haude M, Rebel R, Strauss U, Diets U, Meyer B (1991) Short and long term results after intracoronary stenting in human coronary arteries: Monocenter experience with the balloon expandable Palmaz-Schatz stent. Br Heart J 66:337–346.
Juilliere Y, Serruys PW, Beat KJ, Sigwart U (1988) Contribution of self expansion of stent and addition endoluminal dilatation within the stent on patency of human coronary arteries. Eur Heart J 9(Suppl 1):56(Abstr).
Karrillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, Chevalier B, Commeau P, Cribier A, Eiferman C, Grollier G, Guerin Y, Henri M, Lefevre T, Livarek B, Louvard Y, Marco J, Makowsky S, Monassier JP, Pernes JM, Rioux P, Spaulding J, Zemour G (1996) Intracoronary stent implantation without ultrasound guidance with replacement of conventional anticoagulation therapy by antiplatelet therapy. 30-day clinical outcome of the French multicenter registry. Circulation 94:1519–1527.
Keane D, Buis B, Reifart N, Plokker TH, Ernst J, Mast E, Renkin J, Heyndrick G, Morel M, de Jaegre P, Serruys PW (1994) Clinical and angiographic outcome following implantation of the new less shortening Wallstent in aortocoronary vein graft: Introduction of a second-generation stent in the clinical arena. J Interven Cardiol 7:557–564.
Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugman S, Urban P, den Heijer P, Koch K, Simon R, Morice MC, Crean P, Bonnier H, Wijns W, Danchin N, Bourdonnec C, Morel MA (1996) Continued benefit of coronary stenting versus balloon angioplasty: One-year clinical follow up of the Benestent trial. J Am Coll Cardiol 27:255–261.
Ozaki Y, Keane D, Ruygrok P, van der Giessen WJ, de Feyter P, Serruys PW (1996) Six month clinical and angiographic outcome of the new, less shortening Wallstent in native coronary arteries. Circulation 93:2114–2120.
Ozaki Y, Violaris AG, Hamburger J, Melkert R, Foley D, Keane D, de Feyter P, Serruys PW (1996) Short and long term clinical and quantitative angiographic results with the new, less shortening Wallstent for vessel reconstruction in chronic total occlusion: A quantitative angiographic study. J Am Coll Cardiol 28:354–360.
Rogers C, Edelman ER (1995) Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 91:2995–3001.
Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King III SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL, Fisch C, De Sanctis RW, Dodge HT, Reeves TJ, Weinberg SI (1988) Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. Circulation 78:486–502.
Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfield JW, Cleman MW, Cabin HS, Walker C, Stagg J, Buchbinder M, Tierstein PS, Topol EJ, Savage M, Perez JA, Curry RC, Whitworth H, Sousa E, Tio F, Almagor Y, Ponder R, Penn IM, Leonard B, Levine SL, Fish RD, Palmaz SC (1991) Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 83:148–161.
Serruys PW, de Jaegere P, Bertrand M, Koher G, Marquis JF, Plessens J, Uebis R, Valeix B, Wigand V (1991) Morphologic change in coronary artery stenosis with the Medtronic Wiktor stent: Initial results from the Core Laboratory for quantitative angiography. Catheterization and Cardiovascular Diagnosis 24:237–245.
Serruys PW, Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrix G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van der Heuvel, Delcan J, the BENESTENT study group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Eng J Med 331:489–495.
Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, Meirer B, Goy JJ, Vogt P, Keppenberger L, Sigwart U (1991) Angiographic follow up after placement of a self expanding coronary artery stent. N Engl J Med 324:13–17.
Sigwart U, Puel J, Mirkowitch V, Keppenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701–706.
Strauss BH, Serruys PW, Bertrand ME, Puel J, Meirer B, Goy JJ, Keppenberger L, Rickards AF, Sigwart U, Morel MA, van Swinjdegt EM (1992) Quantitative angiographic follow up of the coronary Wallstent in native vessels and bypass grafts (Europe an experience-March 1986 to March 1990). Am J Cardiol 69:475–481.
Van der Giessen W, Serruys PW, van Bausekom MM, van Woerkens LJ, van Loon H, Soei LK, Strauss BH, Beath KJ, Verdouw PD (1991) Coronary stenting with a new radioopaque balloon expandable endoprosthesis in pigs. Circulation 83:1788–1798.
Von Birgelen C, Gil R, Ruygrok P, Prati F, Mario C, de Feyter P, Serruys PW (1996) Optimized expansion of the Wallstent compared with the Palmaz-Schatz stent: On-line observations with two and three dimensional intracoronary ultrasound after angiographic guidance. Am Heart J 131:1067–1075.
Williams IL, Thomas MR, Robinson NM, Wainwright RJ, Jewitt DE (1996) Angiographic and clinical restenosis following the use of long coronary Wallstents. Catheter Cardiovasc Interv 48:287–293.
Author information
Authors and Affiliations
About this article
Cite this article
Şişman, M.K., Engin, Ö., Arikan, E. et al. The comparison between self-expanding and balloon expandable stent results in left anterior descending artery. International Journal of Angiology 10, 34–40 (2001). https://doi.org/10.1007/BF01616342
Issue Date:
DOI: https://doi.org/10.1007/BF01616342